Vorselaars AD - Search Results

1

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.

Crommelin HA, van der Burg LM, Vorselaars AD, Drent M, van Moorsel CH, Rijkers GT, Deneer VH, Grutters JC. Crommelin HA, et al. Among authors: vorselaars ad. Respir Med. 2016 Jun;115:72-7. doi: 10.1016/j.rmed.2016.04.011. Epub 2016 Apr 23. Respir Med. 2016. PMID: 27215507 Free article.

2

Increased number of pulmonary embolisms in sarcoidosis patients.

Vorselaars ADM, Snijder RJ, Grutters JC. Vorselaars ADM, et al. Chest. 2012 Mar;141(3):826-827. doi: 10.1378/chest.11-2514. Chest. 2012. PMID: 22396572 No abstract available.

3

Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes.

Hijdra D, Vorselaars AD, Grutters JC, Claessen AM, Rijkers GT. Hijdra D, et al. Among authors: vorselaars ad. J Inflamm (Lond). 2012 Oct 5;9(1):38. doi: 10.1186/1476-9255-9-38. J Inflamm (Lond). 2012. PMID: 23039818 Free PMC article.

4

Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M, Thomeer M, van Moorsel CHM, Grutters JC. Vorselaars ADM, et al. Chest. 2013 Sep;144(3):805-812. doi: 10.1378/chest.12-1728. Chest. 2013. PMID: 23538719

5

Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy.

Vorselaars AD, Sjögren EV, van Moorsel CH, Grutters JC. Vorselaars AD, et al. Case Rep Pulmonol. 2013;2013:308092. doi: 10.1155/2013/308092. Epub 2013 May 15. Case Rep Pulmonol. 2013. PMID: 23762724 Free PMC article.

6

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis.

Vorselaars AD, Verwoerd A, van Moorsel CH, Keijsers RG, Rijkers GT, Grutters JC. Vorselaars AD, et al. Eur Respir J. 2014 Feb;43(2):602-9. doi: 10.1183/09031936.00055213. Epub 2013 Aug 29. Eur Respir J. 2014. PMID: 23988768 Free article.

7

Current therapy in sarcoidosis, the role of existing drugs and future medicine.

Vorselaars AD, van Moorsel CH, Deneer VH, Grutters JC. Vorselaars AD, et al. Inflamm Allergy Drug Targets. 2013 Dec;12(6):369-77. doi: 10.2174/18715281113126660062. Inflamm Allergy Drug Targets. 2013. PMID: 24151828 Review.

8

Phenotypic characterization of human intermediate monocytes.

Hijdra D, Vorselaars AD, Grutters JC, Claessen AM, Rijkers GT. Hijdra D, et al. Among authors: vorselaars ad. Front Immunol. 2013 Oct 22;4:339. doi: 10.3389/fimmu.2013.00339. eCollection 2013. Front Immunol. 2013. PMID: 24155746 Free PMC article. No abstract available.

9

Cytotoxic agents in sarcoidosis: which one should we choose?

Vorselaars AD, Cremers JP, Grutters JC, Drent M. Vorselaars AD, et al. Curr Opin Pulm Med. 2014 Sep;20(5):479-87. doi: 10.1097/MCP.0000000000000078. Curr Opin Pulm Med. 2014. PMID: 25046427 Review.

10

Anti-TNF therapeutics for the treatment of sarcoidosis.

Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC. Crommelin HA, et al. Among authors: vorselaars ad. Immunotherapy. 2014;6(10):1127-43. doi: 10.2217/imt.14.65. Immunotherapy. 2014. PMID: 25428650 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page